THE SCHEPENS EYE RES INST INC has a total of 13 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2009. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are SCHEPENS EYE RES INST, UNIV LOMA LINDA and BIOLOG MIMETICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Optics | |
#5 | Computer technology | |
#6 | Control | |
#7 | Organic fine chemistry | |
#8 | Transport |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Diagnosis and surgery | |
#6 | Optical systems | |
#7 | Heterocyclic compounds | |
#8 | Traffic control systems | |
#9 | Vehicle parts | |
#10 | Data recognition and presentation |
# | Name | Total Patents |
---|---|---|
#1 | D'Amore Patricia A | 3 |
#2 | Bex Peter | 3 |
#3 | Dana Reza | 3 |
#4 | Chauhan Sunil | 2 |
#5 | Argüeso Pablo | 1 |
#6 | Kazlauskas Andrius | 1 |
#7 | Saint-Geniez Magali | 1 |
#8 | Guo Xiaoqing | 1 |
#9 | Dorr Michael | 1 |
#10 | Gnanaguru Gopalan | 1 |
Publication | Filing date | Title |
---|---|---|
WO2017176770A1 | Peroxisome proliferator-activated receptor gamma selective agonists for inhibition of retinal pigment epithelium degeneration or geographic atrophy | |
WO2017066758A1 | P38 map kinase inhibitors for wound healing | |
US2017198026A1 | Compositions And Methods For Treating Tumors And Immune Based Inflammatory Diseases | |
US2015243044A1 | Collision prediction |